Cytovance in Agreement with Akshaya
The Journal Record website reported that Cytovance Biologics has entered into a collaboration agreement with Akshaya Bio Inc. to provide rapid access to clinical materials using Akshaya’s proprietary Chimigen Platform Technology for vaccine development for COVID-19 and hepatitis B vaccine. Oklahoma City-based Cytovance Biologics is a contract development
Comments Off on Cytovance in Agreement with Akshaya • Read this story »
More Articles
Corporate Hub as a Governance Structure for Coupled Open Innovation in Large Firms
The Wiley Online Library website posted a study which addresses how the open innovation concept can be applied in large corporations aiming to work with small innovative firms. More specifically, it reports an in depth qualitative study of how AstraZeneca, a global bio-pharmaceutical corporation, designed
Comments Off on Corporate Hub as a Governance Structure for Coupled Open Innovation in Large Firms • Read this story »
Growing Adoption of Open Innovation Models in Pharmaceutical and Biotechnology Companies
The GlobalNewswire website noted that a new study has been released reporting that the growing adoption of open innovation models in pharmaceutical and biotechnology companies and increasing pharmaceutical outsourcing are the key factors driving the growth of the protein stability analysis market. The
Comments Off on Growing Adoption of Open Innovation Models in Pharmaceutical and Biotechnology Companies • Read this story »
Open Innovation and External Sources of Innovation.
The Journal of Translational Medicine noted that historically, research and development (R&D) in the pharmaceutical sector has predominantly been an in-house activity. In recent years, multiple extrinsic and intrinsic factors induced an opening for external sources of innovation and resulted in
Comments Off on Open Innovation and External Sources of Innovation. • Read this story »
Henry Chesbrough on Barriers, Success Stories, and Business Unit Support
The Innovation Leader website posted an article in which Henry Chesbrough discusses why the “inside-out” approach is more challenging for most companies; how open innovation is being practiced at companies like Intel, Eli Lilly, Bayer, and United HealthCare; and some of the common barriers to making
Comments Off on Henry Chesbrough on Barriers, Success Stories, and Business Unit Support • Read this story »
RPS Summit to Focus on Science and Innovation
The Pharmaceutical Journal website reported that the Royal Pharmaceutical Society’s (RPS) inaugural Winter Summit will take place in London on December 5, 2017. The keynote speech, “Open innovation and drug discovery — the structural genomics consortia story”, will be delivered by
Comments Off on RPS Summit to Focus on Science and Innovation • Read this story »
Korean Drugmakers to Seek Global Partnerships
The Korea Herald website reported that South Korean pharmaceutical companies and global drugmakers came together to discuss new business partnerships and open innovation at this year’s Korea Pharma Associations Conference in Seoul. As one of the biggest pharma industry events of the year, the conference
Comments Off on Korean Drugmakers to Seek Global Partnerships • Read this story »
Global Drugmakers Join Hands With Startups
The Yonhapnews website reported that global pharmaceutical companies are seeking to join hands with local startups as part of their effort to increase research and development productivity. The move is part of their effort to adopt “open innovation,” a network of collaboration with external
Comments Off on Global Drugmakers Join Hands With Startups • Read this story »
Bayer Launches Open Innovation Challenge
The Nation website reported that Bayer Pharmaceuticals is addressing the problem of drug adherence in the elderly by launching the “Grants4sApps” challenge in Singapore. The Grants4Apps Bayer-NUS Open Innovation Challenge calls for innovative health tech solutions across countries in Asia-Pacific
Comments Off on Bayer Launches Open Innovation Challenge • Read this story »
Open Innovation Case Studies
The IMI website announced a symposium at the 6th Pharmaceutical Science World Congress: “Putting open innovation into practice–case studies from Europe”. The congress will take place in Stockholm, Sweden, on on May 21 to 24, 2017. IMI is working to facilitate open innovation among the
Comments Off on Open Innovation Case Studies • Read this story »